Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shrinivas Bishu

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Clinical and Translational Gastroenterology|November 29, 2023
Microbiome-Based Therapeutics in Digestive Diseases: What They Are and How Are They RegulatedShrinivas Bishu, Brian Ginnebaugh, Jacqueline Chu, et al.
Alimentary Pharmacology & Therapeutics|August 16, 2019
Letter: immune checkpoint inhibitor-induced colitis-shouldn't we be checking more often? Authors' replyAndrew P Wright, Marc S Piper, Shrinivas Bishu, et al.
Alimentary Pharmacology & Therapeutics|April 30, 2019
Systematic review and case series: flexible sigmoidoscopy identifies most cases of checkpoint inhibitor-induced colitisAndrew P Wright, Marc S Piper, Shrinivas Bishu, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|December 25, 2025
From pain relief to mucosal grief: A comprehensive review of NSAID enteropathyHarsh Srivastava, Tanisha Sehgal, Varun Mehta, et al.
Alimentary Pharmacology & Therapeutics|April 6, 2026
Review Article: TL1A Inhibitors in IBD - Mechanistic Rationale and Clinical EvidenceManjeet Kumar Goyal, Harsh Srivastava, Tanisha Sehgal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 7, 2022
The Role of Tissue Biopsy in the Management of Immune Checkpoint Inhibitor ToxicityLeslie A Fecher, Shrinivas Bishu, Robert J Fontana, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 14, 2009
Voxel-based estimation of kinetic model parameters of the L-[1-(11)C]leucine PET method for determination of regional rates of cerebral protein synthesis: validation and comparison with region-of-interest-based methodsGiampaolo Tomasi, Alessandra Bertoldo, Shrinivas Bishu, et al.
Gastroenterology|October 23, 2020
Efficacy and Outcome of Tofacitinib in Immune checkpoint Inhibitor ColitisShrinivas Bishu, Joanna Melia, William Sharfman, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 4, 2010
A spectral analysis approach for determination of regional rates of cerebral protein synthesis with the L-[1-(11)C]leucine PET methodMattia Veronese, Alessandra Bertoldo, Shrinivas Bishu, et al.
Inflammatory Bowel Diseases|July 12, 2019
Imaging Features Associated With Failure of Nonoperative Management of Intraabdominal Abscesses in Crohn DiseaseDaniel Perl, Akbar K Waljee, Shrinivas Bishu, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Clinical and Translational Gastroenterology|November 29, 2023
Microbiome-Based Therapeutics in Digestive Diseases: What They Are and How Are They RegulatedShrinivas Bishu, Brian Ginnebaugh, Jacqueline Chu, et al.
Alimentary Pharmacology & Therapeutics|August 16, 2019
Letter: immune checkpoint inhibitor-induced colitis-shouldn't we be checking more often? Authors' replyAndrew P Wright, Marc S Piper, Shrinivas Bishu, et al.
Alimentary Pharmacology & Therapeutics|April 30, 2019
Systematic review and case series: flexible sigmoidoscopy identifies most cases of checkpoint inhibitor-induced colitisAndrew P Wright, Marc S Piper, Shrinivas Bishu, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|December 25, 2025
From pain relief to mucosal grief: A comprehensive review of NSAID enteropathyHarsh Srivastava, Tanisha Sehgal, Varun Mehta, et al.
Alimentary Pharmacology & Therapeutics|April 6, 2026
Review Article: TL1A Inhibitors in IBD - Mechanistic Rationale and Clinical EvidenceManjeet Kumar Goyal, Harsh Srivastava, Tanisha Sehgal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 7, 2022
The Role of Tissue Biopsy in the Management of Immune Checkpoint Inhibitor ToxicityLeslie A Fecher, Shrinivas Bishu, Robert J Fontana, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 14, 2009
Voxel-based estimation of kinetic model parameters of the L-[1-(11)C]leucine PET method for determination of regional rates of cerebral protein synthesis: validation and comparison with region-of-interest-based methodsGiampaolo Tomasi, Alessandra Bertoldo, Shrinivas Bishu, et al.
Gastroenterology|October 23, 2020
Efficacy and Outcome of Tofacitinib in Immune checkpoint Inhibitor ColitisShrinivas Bishu, Joanna Melia, William Sharfman, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 4, 2010
A spectral analysis approach for determination of regional rates of cerebral protein synthesis with the L-[1-(11)C]leucine PET methodMattia Veronese, Alessandra Bertoldo, Shrinivas Bishu, et al.
Inflammatory Bowel Diseases|July 12, 2019
Imaging Features Associated With Failure of Nonoperative Management of Intraabdominal Abscesses in Crohn DiseaseDaniel Perl, Akbar K Waljee, Shrinivas Bishu, et al.
Pageof 9